These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 33613723)
1. Expression and inhibitory effects of p53-upregulated modulator of apoptosis in gallbladder carcinoma. Liu Z; Yan C; Xiao Y; Zhang W; Wang L; Li Q; Cai W Oncol Lett; 2021 Mar; 21(3):234. PubMed ID: 33613723 [TBL] [Abstract][Full Text] [Related]
2. Effect of Tian C; Zhang B; Ge C Oncol Lett; 2020 Sep; 20(3):2677-2688. PubMed ID: 32782584 [TBL] [Abstract][Full Text] [Related]
3. Somatostatin enhances the chemosensitivity of GBC-SD cell line to doxorubicin through arresting the cell cycle to S phase rather than through the P53/Bax-depended apoptosis way in vitro. Songgang L; Jiyu L; Gongwei ; Yingbin L; Yiyu Q; Zhiwei Q Hepatogastroenterology; 2009; 56(94-95):1253-60. PubMed ID: 19950772 [TBL] [Abstract][Full Text] [Related]
4. PUMA decreases the growth of prostate cancer PC-3 cells independent of p53. Shan Z; Liu Q; Li Y; Wu J; Sun D; Gao Z Oncol Lett; 2017 Mar; 13(3):1885-1890. PubMed ID: 28454339 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of deleted in liver cancer 1 gene on gallbladder cancer growth through induction of cell cycle arrest and apoptosis. Qin Y; Chu B; Gong W; Wang J; Tang Z; Shen J; Quan Z J Gastroenterol Hepatol; 2014 May; 29(5):964-72. PubMed ID: 24329682 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of SNORA21 suppresses tumorgenesis of gallbladder cancer in vitro and in vivo. Qin Y; Zhou Y; Ge A; Chang L; Shi H; Fu Y; Luo Q Biomed Pharmacother; 2019 Oct; 118():109266. PubMed ID: 31401397 [TBL] [Abstract][Full Text] [Related]
7. SLC25A22 promotes proliferation and metastasis by activating MAPK/ERK pathway in gallbladder cancer. Du P; Liang H; Fu X; Wu P; Wang C; Chen H; Zheng B; Zhang J; Hu S; Zeng R; Liang B; Fang L Cancer Cell Int; 2019; 19():33. PubMed ID: 30814911 [TBL] [Abstract][Full Text] [Related]
8. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway. Shu YJ; Weng H; Ye YY; Hu YP; Bao RF; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Wu XS; Li ML; Jiang L; Lu W; Han BS; Jie ZG; Liu YB Mol Cancer; 2015 Jan; 14(1):12. PubMed ID: 25623055 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro. Fan YZ; Fu JY; Zhao ZM; Chen CQ Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):72-80. PubMed ID: 17287171 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA TUG1 promotes cell proliferation and metastasis by negatively regulating miR-300 in gallbladder carcinoma. Ma F; Wang SH; Cai Q; Jin LY; Zhou D; Ding J; Quan ZW Biomed Pharmacother; 2017 Apr; 88():863-869. PubMed ID: 28178615 [TBL] [Abstract][Full Text] [Related]
11. Curcumin induces apoptosis in gallbladder carcinoma cell line GBC-SD cells. Liu TY; Tan ZJ; Jiang L; Gu JF; Wu XS; Cao Y; Li ML; Wu KJ; Liu YB Cancer Cell Int; 2013 Jun; 13(1):64. PubMed ID: 23802572 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of LncRNA AFAP1-AS1 predicts poor prognosis and promotes cells proliferation and invasion in gallbladder cancer. Ma F; Wang SH; Cai Q; Zhang MD; Yang Y; Ding J Biomed Pharmacother; 2016 Dec; 84():1249-1255. PubMed ID: 27810781 [TBL] [Abstract][Full Text] [Related]
13. Bmi-1 in gallbladder carcinoma: Clinicopathology and mechanism of regulation of human gallbladder carcinoma proliferation. Jiao K; Jiang W; Zhao C; Su D; Zhang H Oncol Lett; 2019 Aug; 18(2):1365-1371. PubMed ID: 31423199 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of microRNA‑494 inhibits cell proliferation in lung squamous cell carcinoma via the induction of PUMA‑α‑mediated apoptosis. Gao X; Yang X; He F; Liu X; Liu D; Yuan X Exp Ther Med; 2023 Jun; 25(6):242. PubMed ID: 37153893 [TBL] [Abstract][Full Text] [Related]
15. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer. Cao Y; Liang H; Zhang F; Luan Z; Zhao S; Wang XA; Liu S; Bao R; Shu Y; Ma Q; Zhu J; Liu Y J Exp Clin Cancer Res; 2016 Apr; 35():68. PubMed ID: 27084680 [TBL] [Abstract][Full Text] [Related]
16. Exogenous p53 upregulated modulator of apoptosis (PUMA) decreases growth of lung cancer A549 cells. Liu CJ; Zhang XL; Luo DY; Zhu WF; Wan HF; Yang JP; Yang XJ; Wan FS Asian Pac J Cancer Prev; 2015; 16(2):741-6. PubMed ID: 25684518 [TBL] [Abstract][Full Text] [Related]
17. UHRF1 depletion suppresses growth of gallbladder cancer cells through induction of apoptosis and cell cycle arrest. Qin Y; Wang J; Gong W; Zhang M; Tang Z; Zhang J; Quan Z Oncol Rep; 2014 Jun; 31(6):2635-43. PubMed ID: 24756644 [TBL] [Abstract][Full Text] [Related]
18. Upregulation of H19 indicates a poor prognosis in gallbladder carcinoma and promotes epithelial-mesenchymal transition. Wang SH; Wu XC; Zhang MD; Weng MZ; Zhou D; Quan ZW Am J Cancer Res; 2016; 6(1):15-26. PubMed ID: 27073719 [TBL] [Abstract][Full Text] [Related]
19. Upregulation of long non-coding RNA HOXA-AS2 promotes proliferation and induces epithelial-mesenchymal transition in gallbladder carcinoma. Zhang P; Cao P; Zhu X; Pan M; Zhong K; He R; Li Y; Jiao X; Gao Y Oncotarget; 2017 May; 8(20):33137-33143. PubMed ID: 28388535 [TBL] [Abstract][Full Text] [Related]
20. Parthenolide induces gallbladder cancer cell apoptosis via MAPK signalling. Obulkasim H; Aji G; Abudoula A; Liu Y; Duan S Ann Med Surg (Lond); 2024 Apr; 86(4):1956-1966. PubMed ID: 38576937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]